John Jakob, MD PhD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Columbia University College of Physicians & Surgeons
Medical School
Case Western Reserve University - University Hospitals
Residency
University of Texas MD Anderson Cancer Center
Fellowship
American Board of Internal Medicine - Oncology
KY State Medical License: 2017 - Present
OH State Medical License: 2011 - 2018
Inactive TX: 2008 - 2014
American Board of Internal Medicine: Hematology
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Internal Medicine
Mercy Medical Center Canton
Languages: English/Spanish
+1 330-489-1000
1320 Mercy Drive Northwest
Read MoreA Phase II study of Gefitinib in Patients with Advanced Salivary Gland Cancers.
Jakob JA Kies MS Glisson BS Kupferman ME Liu DD Lee JJ El-Naggar AK Gonzalez-Angulo AM Blumenschein GR; Head Neck. 2014 Mar 2 .
See more >>Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
Bucheit, A. D.,Syklawer, E.,Jakob, J. A.,Bassett, R. L.,Curry, J. L.,Gershenwald, J. E.,Kim, K. B.,Hwu, P.,Lazar, A. J.,Davies, M. A.; Cancer. 2013 Aug 6.
See more >>Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.
Joseph RW Eckel-Passow JE Sharma R Liu P Parker A Jakob J Buchbinder E Bassett RL Davies MA Hwu P Atkins MB Sullivan RJ; J Immunother. 2012 Nov-Dec .
See more >>